The Division of Neurology II (DN II) regulates and reviews Investigational New Drug (IND) applications and marketing applications for drug and biologic products for the treatment of seizures, epilepsies, medical countermeasures, migraine, other headaches, traumatic brain Injury, inner ear disorders, stroke, and neuroimmunologic disorders (e.g., Multiple Sclerosis).
Food and Drug Administration
Center for Drug Evaluation and Research
Division of Neurology (DN II)
10903 New Hampshire Avenue, Silver Spring, MD 20993
Building 22, Suite 4346
Phone: (301) 796-2250
Fax: (301) 796-9842